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Dissolution rateAbstract The fabrication and the performance response characteristics of a sensitive, selective,
simple, and rapid sensor for the determination of clopidogrel bisulfate (CLO-H2SO4) were
described. The constructed carbon paste sensor comprised of an ion-pair based on clopidogrel with
silicotungstate (CLO-ST) where this study included: composition, usable pH range, response time
and temperature. The sensor exhibited a wide linear dynamic concentration ranging from
1.00 · 107 to 1.00 · 102 and the usable pH ranges from 1.2 to 4.8 with the response time ranging
from 5 to 8 s which is much faster compared to liquid ISEs with a detection limit equalling 0.34 nM.
The selectivity of the sensor (CLO-H2SO4) was applied with respect to many of organic and inor-
ganic cations, amino acids and sugars. The sensor had applications in bulk powder, tablets, humans
(serum-urine) and in monitoring Plavix tablets’ dissolution rates. The obtained results were statis-
tically analyzed for both accuracy and precision and were compared using the US pharmacopeial
method where no signiﬁcant difference was observed.
ª 2014 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Clopidogrel bisulfate is methyl (+)-(S)-a-(2-chlorophenyl)-6,
7-dihydrothieno[3,2-c]pyridine-5(4H)-acetate sulfate (1:1) with
molecular formula C16H16ClNO2S.H2SO4 and its molecular
mass equals 419.9 as shown in Fig. 1 Plavix is a trademarkprescription medicine used to treat people who have any of
the following:
Heart attack, Stroke or Recent Stroke, Chest Pain due to
Heart problems, Poor circulation in their legs (peripheral arte-
rial disease), Acute Coronary Syndrome (ACS), and Estab-
lished Peripheral Arterial Disease. Clopidogrel reduces the
risk of heart attack and stroke in people who have cardiovas-
cular disorders (Budavari, 2011; Henein, 2006; Gomes et al.,
2004; Taubert et al., 2004). Clopidogrel reduces the chance
of arterial blockage, by inhibiting platelet aggregation, thus
preventing heart attacks and strokes.
The literature survey review refers to a variety of analytical
methods such as spectrophotometric methods for the determi-
nation of CLO (YogitaShete et al., 2009; Game et al., 2010;modiﬁed
2 A.F. KhorshidGurav et al., 2011; Cholke et al., 2012; Rujput et al., 2008).
Quantitatively kinetic spectrophotometric for CLO, petaxolol
and imidril in its dosage form (El Yazbi et al., 2010). Other
methods included nonenzymatic and enzymatic chiral inver-
sion of CLO utilizing NMR and the HPLC chiral method
(Reist et al., 2000). The analysis by GC–MS for metabolite car-
boxylic acid of CLO in serum and plasma (Lagorce et al.,
1998), reverse phase HPLC with UV detection for estimation
of CLO in its dosage form were presented in Shrivastava
et al. (2008), Alarfaj (2010), Panda (2010), Londhe et al.
(2011), Sultana et al. (2011), HPTLC Petal et al., 2008;
Sinha et al., 2009 and HPLC (Saber et al., 2007; Shu-qin
et al., 2008; Javed et al., 2011). CLO was determined in the
presence of its human ﬂuid by mass spectrometry coupled with
LC (Shin and Yoo, 2007; Takahashi et al., 2008), and
HPLCMS/MS (Silvestro et al., 2011). Also capillary electro-
phoretic (Fayed et al., 2009; Karazniewicz et al., 2010; Serra
et al., 2010), and voltammetric (Dermis and Aydogan, 2010)
methods were reported. No methods are found in the literature
for the determination of CLO by chemical modiﬁed carbon
paste (CMCP).
Applications in electrochemistry and electroanalysis make
carbon paste-based sensors one of the most popular sensor
materials with almost unlimited applicability in basic research,
highly specialized investigations, as well as in practically ori-
ented electroanalysis (Moghaddam et al., 2014; Sˇvancara
et al., 2009a,b).
This work describes the fabrication, construction with sen-
sor potentiometric characterization, and application of clopi-
dogrel-chemically modiﬁed carbon paste sensors (CLO-
CMCPSs), using the following ion-pairs; clopidogrel silico-
tungstate (CLO-ST), clopidogrel silicomolybdate (CLO-SM),
clopidogrel phosphotungstate (CLO-PT), clopidogrel phos-
phomolybdate (CLO-PM), clopidogrel tetraphenylborate
(CLO-TPB) and clopidogrel reineckate (CLO-Rein) with sol-
vent mediator 2-Nitrophenyl phenyl ether (2-NPPE) and com-
pares them with sensors previously reported (Saber et al., 2008;
Bin-Ibrahim et al., 2012).
2. Experimental
2.1. Chemicals and materials
All chemicals used for preparation of solutions were of analyt-
ical grade. Doubly distilled water was used throughout all the
experiments. Clopidogrel bisulfate and its dosage form (Plavix,
75 mg /tablet) were provided by Sanoﬁ Aventis Company
Cairo-A.R.E. Tributyl phthalate (TBP), tricresyl phthalate
(TCP), graphite powder, dibutyl phthalate (DBP), dioctyl
phthalate (DOP), 2-nitrophenyl phenyl ether (2-NPPE),
ammonium reineckate (AmmRein), sodium tetraphenylborateSO3HCOOCH3
Cl
S
N
.
Figure 1 The chemical structure of clopidogrel bisulfate.
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(SMA), phosphomolybdic acid (PMA), and phosphotungstic
acid (PTA), were selective products from Aldrich.
0.5 M chloride solutions of each of the following cations:
NH4
+, K+, Na+, Zn2+, Ni2+, Co2+, Cu2+, Mg2+, Ba2+,
Mn2+, Cr3+, and Fe3+solutions (1000 lg ml1) were obtained
from Merck. Glucose anhydrous, lactose monohydrate, malt-
ose, urea, ascorbic acid, aspirin, L-threonine, L-lysine, L-cystine,
and L-glycine were obtained from Aldrich. Serum was used
within 24 h as provided byVACSERA (Giza, Egypt) while urine
samples were obtained from healthy volunteers. Corn oil,
sodium hydroxide and hydrochloric acid are from NODCAR.
2.2. The Electrochemical system
The potentiometric measurements were carried out with a Jen-
way 3515 digital pH/mV meter. A WTW-packed saturated cal-
omel sensor (SCE) was used as an external reference sensor. The
electrochemical system was as follows: CMCPS/test solution//
SCE. The dissolution proﬁle was studied using the USP XXXII
(United States Pharmacopeia, 2009) method with the paddle
apparatus II (Liddell et al., 2007). The apparatuses used for this
purpose is model ‘‘SR8Plus’’, CA USA Hanson Research, with
number ’’73–100-116’’) and the spectrophotometer double
beam instrument UV-1800–2011 Shimadzu (Japan).
2.3. Sensor preparation
Chemically modiﬁed carbon paste sensors were prepared as
previously described (Khorshid and Issa, 2014). The sensor
was used directly for potentiometric measurements without
preconditioning requirements. A fresh surface of the paste
was obtained by squeezing more out. The surplus paste was
wiped out and the freshly exposed surface was polished on a
paper until the surface showed shiny appearance.
2.4. Construction of the calibration graphs
Different compositions covering the ranges of 0.5–5% of CLO
were prepared. The measured potential was recorded using the
present sensor. Data were plotted as potential versus logarithm
of the drug concentration CLO+ activity and the calibration
graph was used for subsequent determination of unknown
drug concentration.
2.5. Effect of pH
The effect of pH of the test solution on the sensor was inves-
tigated by measuring its potential in solutions prepared in
the concentration range of 1.0 · 105–1.0 · 103 M by serial
dilution. The sample solution pH was monitored simulta-
neously with a conventional glass pH sensor. The emf readings
were taken after the potential reached a constant value. The
mV-readings were plotted against the pH-values for the differ-
ent concentrations.
2.6. Effect of temperature on the sensor potential
The thermal stability of the sensors with calibration graphs
was studied covering the range of 25–50 C of different test
solution-temperatures. The values of E were plotted versusfate in plavix tablet and human biological ﬂuids utilizing chemically modiﬁed
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sors. The isothermal coefﬁcient (dE/dt) of the cell represents
the slope of this line obtained by plotting of Ecell versus (t-
25) and was calculated for each sensor by the following equa-
tion (Antropov’s equation):
Ecell ¼ E25Cþ ðdE=dtÞðt 25Þ
By subtraction of the standard sensor potential of the calo-
mel sensor (241.2, 234.4, 230.88 and 223.57 mV) at different
temperatures (25, 35, 40 and 50 C) the values of the standard
potentials of sensors (Eelec.) were calculated.
2.7. Sensor selectivity
The matched potential method (MPM) (Umezawa et al., 2000,
1995) was applied as the previously reported method
(Khorshid and Issa, 2014).
The following equation is used to calculate the selectivity
values of log Kpot
CLO;Jzþ :
Kpot
CLO:Jzþ ¼
ðaA  adrugÞ
aj
where: aA is the initial concentration of drug, adrug is the activ-
ity of the added drug and aj is the activity of the added inter-
fering ion producing the same increase in potential.
The separate solutions method (SSM) (Guilbault et al.,
1976) was applied, to conﬁrm (MPM):
Two potential values were measured for the same concen-
tration of the drug and the interferents. The selectivity values
of log Kpot
CLO;Jzþ are calculated using the following equation:
log Kpot
CLO;Jzþ ¼
E2  E1
S
þ log ½Drug  log ½Jzþ1=2
where: E1 and E2 are the sensor potentials of 10
3 M solution
of each of the CLO drug and interfering cation, Jz+, respec-
tively and S is the slope of the calibration graph.
2.8. Potentiometric determination of CLO
Small portions (0.1 ml) of standard 102 M CLO solution were
added to 50 ml water-containing different concentrations of
drug ranging from 106 to 104 M or its pharmaceutical dos-
age form using the following equation:
Cx ¼ Cs Vs
Vx þ Vs
 
10nðDE=SÞ  Vx
Vs þ Vx
 1
where Cx is the concentration to be determined, Vx is the vol-
ume of the original sample solution, Vs and Cs are the volume
and concentration of the standard solution added to the sam-
ple to be analyzed, respectively, DE is the change in potential
after addition of certain volume of standard solution, and S
is the slope of the calibration graph. Unknown drug concen-
tration was determined from the graph produced by plotting
the logarithm of CLO+ activity versus the potential.
In the potentiometric titrations different concentrations that
ranged from 2.09 to 41.99 mg of drug were dissolved in 50 ml bi-
distilled water. Different volumes of this solution (1.0–5.0 mL)
were taken and subjected against 0.0025 M STA, 0.0025 SMA,
0.0033 PTA, 0.0033 PMA, 0.01 M (NaTPB and AmmRein)
using the sensor(s). Conventional S-shaped curves with ﬁrst
and second plots were used to determine the end points.Please cite this article in press as: Khorshid, A.F. New analysis of clopidogrel bisul
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For sampling of tablets, ﬁve plavix tablets (75 mg/tablet) were
powdered together to ﬁne powder. An accurately weighed por-
tion was taken from this powder, was added to 50 ml bidis-
tilled water and the solution was completed to the mark with
bidistilled water then shaken. The standard addition technique
was applied for the potentiometric determination.
2.10. Content uniformity assay of plavix tablets<905>
(Liddell et al., 2007)
One tablet of Plavix (75 mg/tablet) was immersed in the mea-
suring ﬂask and adjusted to pH 1; for measuring each sensor it
was immediately immersed in the sample solution three times
and then washed between each individual measurement with
distilled water to reach steady potential. The content unifor-
mity was evaluated from the calibration graph by using the
mean potential. For the spectrophotometric measurements
by employing UV absorbance k max 240 nm with the standard
solution.
2.11. Determination of CLO in biological ﬂuids
2.11.1. In serum
One mL of standard drug solution with 1 · 103, 1 · 104 and
1 · 105 M was added into three centrifugation 20-ml stop-
pered shaking tubes (Bin-Ibrahim et al., 2012). Solution in each
tube of 9 ml of serum and 0.1 N acetate buffers was added to
serum solution dropwise until the suitable pH was obtained.
The tubes were shaken well for 1 min and 10.0 mL of diethyl
ether was added to each tube and centrifuged for 2 min at
1500 rpm. Then, the deproteinated layer was transferred to a
100-mLmeasuring ﬂask and completed to the mark using bidis-
tilled water. The modiﬁed sensor was immersed in conjunction
with the reference sensor in these solutions and then washed
with water between measurements. The emf produced for each
solution was measured by the proposed sensor, and the concen-
tration of CLO-H2SO4 was determined from the corresponding
sensor calibration and standard addition methods.
2.12. In spiked urine
For urine analysis, different quantities of the drug and 5 ml
urine were transferred to a 100 ml volumetric ﬂask and left stir-
red for 5 min, completed to the mark with doubly bidistilled
water and a small volume of (0.1–2.0 ml) 0.01 M HCl was
added to give solutions of pH ranging from 4 to 5 and concen-
trations from 1.0 · 106 to 5.0 · 104 M drug. These solutions
were subjected to the standard addition method for drug
determination.
2.13. Dissolution <711> (Liddell et al., 2007)
One tablet of Plavix (75 mg/tablet) was placed in the vessel of
instrument apparatus II. In vitro release study the dissolution
medium (900 ml of 0.01 M HCl) pH 1.2 was maintained at
37 ± 0.5 C for 2 h. The clopidogrel was kept in a hard gelatin
capsule so the vessel was rotated at 50 rpm. At appropriate
time intervals, the potential values were recorded using thefate in plavix tablet and human biological ﬂuids utilizing chemically modiﬁed
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sor (SCE) reference sensor and the amount of clopidogrel
released was calculated from the calibration graph. For the
spectrophotometric measurements, 5.0 ml aliquots of the dis-
solution solution were withdrawn, ﬁltered, diluted with
0.01 M HCl and the concentration of samples was analyzed
using a UV spectrophotometer (1800, Shimadzu, Japan) and
the absorbencies were measured at k max 240 nm. A calibra-
tion graph was used for drug release calculation.3. Result and discussion
3.1. Composition and performance characteristics of CLO
sensors
The paste with no exchangers displayed no measurable
response toward clopidogrel (CLO+) ion. For this purpose,
the ion-associates of CLO4ST, CLO4SM, CLO3PT, CLO3PM,
CLO-TPB and CLO-Rein were prepared. The chemical com-
position of the precipitates was identiﬁed and conﬁrmed by ele-
mental analysis (C, H, and N) at the Microanalysis Center,
Cairo University, Egypt. The results are shown in Table 1.
While the investigated as modiﬁers for carbon paste sensors
selective to clopidogrel as shown in Table 2. The inﬂuence of
the binder type and concentration on the characteristics of
the studied sensors was investigated by using six binders with
different polarities including 2-NPPE, TCP, DOP DBP, TBP
and Corn Oil.
Different binder/graphite (w/w) ratios were studied. The
sensor with 2-NPPE as a solvent mediator produced the best
response, as shown in Fig. 2, likely due to better dielectric
characteristics of 2-NPPE compared to other solvents, and
the ability of 2-NPPE to extract clopidogrel ions from the
aqueous solution to the organic paste phase.
Among the different compositions studied, a paste contain-
ing ion-exchanger complex 5.0 wt% CLO4ST, 54.0 wt%
graphite, and 41.0 wt% 2-NPPE exhibited the best response
characteristics and also the lowest detection limit. Therefore,
this composition was used to study various operation parame-
ters of the sensor and the optimum composition for the best
sensor is given in Table 3. This sensor was chosen in this study
and its electrochemical performance characteristics were sys-
tematically evaluated according to IUPAC recommendation
(Guilbault et al., 1976; Linder and Umezawa, 2008).Table 1 Elemental analyses of the ion-associates.
Ion-associate Color Tentative formulae
CLO4-ST (Oﬀ-white) [C16H16 ClNO2S]4 [SiW12O
CLO4-SM (Buﬀ) [C16H16 ClNO2S]4 [SiMo12
CLO3-PT (Y. white) [C16H16 ClNO2S]3 [PW12O
CLO3-PM (Faint yellow) [C16H16 ClNO2S]3 [PMo12O
CLO-TPB (White) [C16H16 ClNO2S] [C24H20B
CLO-Rein (Faint pink) [C16H16 ClNO2S] [Cr(NH3
Please cite this article in press as: Khorshid, A.F. New analysis of clopidogrel bisul
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The repeatability of the potential reading of the CLO-ST/
CMCP sensor was examined by subsequent measurements in
1.0 · 103 M CLO-H2SO4 solution immediately after measur-
ing the ﬁrst set of solutions at 1.0 · 104 M CLO-H2SO4. The
standard deviation for 5 replicate measurements of emf was
found to be 0.473 in 1 · 104 M solution and 0.816 in 1 · 10
3 solution.
It was noticed that the slope of the calibration graph
obtained by CLO-ST/CMCPS was nearly constant by polish-
ing for any time taken days and then starts to decrease gradu-
ally without polishing so it consider as a new sensor with every
one polishing to the sensor. After any period of time a new sec-
tion from the master paste was found to function properly.
3.3. Dynamic response time
The dynamic response time (Skoog et al., 1997) of sensor was
tested by measuring the time required to achieve a steady-state
potential (within ± 1 mV) after successive immersions of the
sensor in a series of drug solutions, each having a 10-fold
increase in concentration from1.0· 107 to 1.0· 102M. In this
study, practical response time was recorded by increasing CLO
concentration by up to 10-fold.When the sensor was transferred
fromone concentration solution to another one, it was stabilized
to a value higher than its value (8 s), which may be due to its
memory effect. The sensor yielded steady potential within 10–
12 s. This is most probably due to the fast exchange kinetics of
association–dissociation of clopidogrel ion with the ionophores
at the solution–paste interface. The potential–time plot for the
response of the sensor CLO-ST is shown in Fig. 3.
3.4. Effect of pH
The potential pH proﬁle obtained indicates that the responses
of the sensors are fairly constant over the pH range of 1.2–4.8;
in this range the sensor can be safely used for CLO determina-
tion. For quantitative measurements with ion selective sensors,
studies were carried out to reach the optimum experimental
conditions. Therefore, the pH range from 1.2 to 4.8 was
assumed to be the working pH range of the sensors. It can
be seen from Fig. 4 that at pH values lower than the previously
mentioned pH ranges, the potential readings increase whichC% H% N%
40] Found 23.25 1.96 1.66
(Calc.) 23.28 1.94 1.69
O40] Found 34.25 2.80 2.41
(Calc.) 34.28 2.86 2.39
40] Found 17.40 1.44 1.25
(Calc.) 17.45 1.45 1.27
40] Found 25.66 2.16 1.86
(Calc.) 25.68 2.14 1.87
] Found 64.93 4.80 1.87
(Calc.) 64.94 4.87 1.89
)2(SCN)4] Found 26.11 2.97 13.24
(Calc.) 26.00 2.98 13.27
fate in plavix tablet and human biological ﬂuids utilizing chemically modiﬁed
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Table 2 Composition and slope of calibration curves for different clopidogrel carbon paste sensors at 25.0 ± 0.1 C.
Composition% w/w
Ion-exchanger Graphite 2-NPPE Slope (mV/decade) Linear range (M)
CLO4ST
1.0 54.0 45.0 55.5 ± 0.5 1.0 · 105–5.0 · 103
3.0 54.0 43.0 58.9 ± 1.0 5.0 · 106–1.0 · 102
5.0 54.0 41.0 60.0 ± 0.5* 1.0 · 107–1.0 · 102
CLO4SM
1.0 54.0 45.0 48.7 ± 1.5 5.0 · 105–5.0 · 103
3.0 54.0 43.0 57.9 ± 0.5 5.0 · 105–5.0 · 103
5.0 54.0 41.0 56.3 ± 1.5 8.0 · 105–5.0 · 103
CLO3PT
1.0 54.0 45.0 56.7 ± 1.0 5.0 · 105–1.0 · 103
3.0 54.0 43.0 51.5 ± 1.0 5.0 · 106–5.0 · 103
5.0 54.0 41.0 58.5 ± 0.5 1.0 · 1 06–1.0 · 102
CLO3PM
1.0 54.0 45.0 53.2 ± 1.1 5.0 · 105–1.0 · 102
3.0 54.0 43.0 56.1 ± 1.2 5.0 · 105–1.0 · 102
5.0 54.0 41.0 56.0 ± 0.8 5.0 · 105–1.0 · 102
CLOTPB
1.0 54.0 45.0 56.0 ± 1.7 1.0 · 105–1.0 · 102
3.0 54.0 43.0 53.3 ± 1.1 3.0 · 105–8.0 · 103
5.0 54.0 41.0 57.6 ± 1.5 5.0 · 106–1.0 · 102
CLORein
1.0 54.0 45.0 55.0 ± 1.7 5.0 · 105–1.0 · 102
3.0 54.0 43.0 52.3 ± 1.1 5.0 · 105–8.0 · 103
5.0 54.0 41.0 57.5 ± 1.5 7.0 · 106–1.0 · 102
Binders
2-NPPE+ 54.0 41.0 60.0 ± 0.5 1.0 · 107–1.0 · 102
TCP 54.0 41.0 58.5 ± 0.5 5.0 · 107–1.0 · 102
DOP 54.0 41.0 56.8 ± 0.5 1.0 · 106–5.0 · 103
DBP 54.0 41.0 53.2 ± 0.5 5.0 · 106–5.0 · 103
TBP 54.0 41.0 52.0 ± 0.5 1.0 · 107–5.0 · 103
Corn Oil (Aﬁa) 54.0 41.0 57.0 ± 0.5 5.0 · 108–1.0 · 104
* Selected composition: 5% CLO-ST with different binders.
+ Selected Binder.
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values higher than pH 4.8, the potential readings decrease
gradually due to the formation of free base of the drug and
decrease of the protonated species in the test solutions as
shown in Fig. 4.
3.5. Effect of temperature
3.5.1. Thermal stability of the sensors
To study the thermal stability of the sensors, calibration
graphs (emf, mV vs. pDrug) were constructed at different test
solution temperatures covering the range of 25–50 C. The
results indicate that the slopes of the calibration graphs are still
in the Nernstian range in spite of the increase of the tempera-
ture of the test solutions up to 50 C as shown in Fig. 5a.
3.5.2. Determination of the thermal coefﬁcient of the sensors
The potential of ion-selective sensors is usually affected by the
temperature of the test solution. A thermally stable sensor is
characterized by low thermal temperature coefﬁcient. This
means the successful applicability of the sensor over awide rangePlease cite this article in press as: Khorshid, A.F. New analysis of clopidogrel bisul
carbon paste sensor. Arabian Journal of Chemistry (2014), http://dx.doi.org/10.1016of temperatures. To calculate the thermal coefﬁcient of the cell
(dE/dt)cell, the standard cell potentials, Ecell, were determined
at different temperatures from the respective calibration plots as
the intercept of these plots at p Drug = 0. Knowing that Ecell is
related to (dE/dt) by (Antropov’s equation):
Ecell ¼ E25Cþ ðdE=dtÞðt 25ÞC
Plot of Ecell versus (t-25) C produced a straight line; the
slope of this line is taken as the thermal coefﬁcient of the cell,
as shown in Fig. 5b. The value of the standard potentials of
sensor (Eelec.) was calculated after the subtraction of the
standard sensor potential of the calomel sensor at different
temperatures (the values are 241.2, 234.4, 230.88 and
223.57 mV at 25, 35, 40 and 50 C, respectively). Plots of
(Eelec.) versus (t-25) C gave a straight line. The slope of the
line was taken as the thermal coefﬁcient of the sensor.
The isothermal coefﬁcient (dEelec./dt) of the sensorwas calcu-
lated and found to be 0.0001 V C1 and (dEcell/dt) equals
0.0005 V C1. These values indicate a fairly high thermal sta-
bility of the sensor within the temperature range investigated
and show no large deviation from the theoretical Nernstian
behavior.fate in plavix tablet and human biological ﬂuids utilizing chemically modiﬁed
/j.arabjc.2014.08.001
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Figure 2 Effect of different plasticizers on the response of 5%
CLO-ST.
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Figure 3 Potential-time plot for response of the
CLO-ST/CMCPS.
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The selectivity coefﬁcients presented in Table 4 indicate that,
CLO-ST sensor is highly selective to clopidogrel cation. Most
inorganic cations do not interfere because of the difference in
their mobility and permeability as compared to clopidogrel
cation. In the case of sugars and amino acids the high selectiv-
ity is related to the difference in polarity and lipophilic nature
of their molecules relative to clopidogrel cation.
3.7. Quantiﬁcation of CLO
In order to assess the validity of the proposed sensor, the ana-
lytical applications involve determination of the drug in its
bulk powder, pharmaceutical preparation (Plavix 75 mg) andTable 3 Response characteristics of CLO-CMCPS at 95%
conﬁdence intervals at 25.0 ± 0.1 C.
Sensor-composition (W/W%) (5% CLO4ST,54% graphite,
41% 2-NPPE)
Slope (mV/decade) 60.0 ± 0.5
Correlation coeﬃcient (r) 0.999
Limit of detection (M) 3.5 · 108
Linear range (M) 1.0 · 107–1.0 · 102
Working pH range 1.2–4.8
Response time (s) 68
Accuracy (%) 99.87 ± 0.177
Standard deviation (%) 0.326
Robustness 99.79 ± 0.23
Ruggedness 99.83 ± 0.26
Please cite this article in press as: Khorshid, A.F. New analysis of clopidogrel bisul
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dard addition method (Guilbault et al., 1976), the percentage
recovery for determinations of CLO in pure solution, Plavix
Tablets and in spiked urine & human serum ranged from
98.2% to 99.3%, 98.0–99.0, 98.3–99.0 and 97.6–98.3 respec-
tively, (Table 5).
While in the Calibration curve method the percentage
recovery for determinations of CLO in pure solution and Pla-
vix Tablets ranged from 98.0 to 99.4 and 98.3 to 98.7, respec-
tively. The potentiometric titration technique usually offers the
advantage of high accuracy and precision, a further advantage
is that the potential break at the titration end-point must be
well deﬁned. The titration process was carried out manually
in aqueous solution containing 4.20–42.0 mg CLO with aver-
age recoveries of 98.2–99.6% using NaTPB as titrant, 97.3–
98.5% in Plavix tablets.
On using PTA as titrant, 97.6–99.3%, 97.0–99.0%, on
using SMA as titrant, 98.0–99.7%, 97.0–99.4, and on using
PMA as titrant, 98.0–99.8%, 97.8–99.5% for pure solution
and Plavix tablets respectively, Fig. 6. The results applying
the potentiometric titration method Table 5. The results
obtained were compared with those of the ofﬁcial method
(United States Pharmacopeia, 2009). No signiﬁcant difference
between two methods was observed with respect to accuracy
and precision (Table 6).
3.8. Validation of the proposed method
3.8.1. Linearity and detection limit (LOD)
Under the optimal experimental CMCPS conditions, a linear
relationship exists between the sensor potential/mV and the
logarithm of corresponding concentration of the investigated
drug, the value of LOD was indicating that the proposed
method is sensitive for detection of very small concentrations
of CLO reaching 0.35 nM. The correlation coefﬁcient (r) and
other statistical parameters are listed in Table 3.
3.8.2. Accuracy
The accuracy of the proposed CMCPS method was investi-
gated by the determination of CLO in its pharmaceutical prep-
arations without interfering from the co formulated adjuvant as
indicated by the mean recovery value of 99.87 ± 0.177 mV/
decade for the investigated sensor.fate in plavix tablet and human biological ﬂuids utilizing chemically modiﬁed
6/j.arabjc.2014.08.001
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Figure 4 Effect of pH on the response of CLO-ST/CMCPS.
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Figure 5b Variation of standard electrode potential and stan-
dard potential of the cell containing CLO-ST/CMCPS with
changes of test solution temperatures.
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The precision of the CMCPS method measured as percentage
relative standard deviation (% RDS) was tested by repeating
the proposed CMCPS method for analysis of the investigated
CLO in intra-day (within the day) and inter-day (consecutive
days) to ﬁve replicates. The obtained %RSD values were
0.379%, 0.466% for the sensor. The % R.S.D. values are less
than 2%, indicating good precision.pCLO
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Figure 5a Calibration graphs for CLO-ST/CMCPS at the test
solution temperatures 25 C (a), 35 C (b), 40 C (c) and 50 C (d).
Please cite this article in press as: Khorshid, A.F. New analysis of clopidogrel bisul
carbon paste sensor. Arabian Journal of Chemistry (2014), http://dx.doi.org/10.10163.9. Analytical applications
The standard addition method was proved to be successful for
the determination of clopidogrel in its bulk solutions, Plavix
tablet (75 mg/tablet) and biological ﬂuids such as human
serum/urine using its prepared chemically modiﬁed carbon
paste sensor.
3.9.1. Determination of Plavix tablet (75 mg/tablet)
In order to assess the validity of the proposed sensor, the stan-
dard addition method (Guilbault et al., 1976), calibration
curve method and the potentiometric titration method (Table
5, Fig. 6) show the determination of CLO in its bulk solutions
and tablet. The results also prove the applicability of the three
methods for the determination of CLO in the pharmaceutical
formulation.
3.9.2. Determination of CLO in human serum and urine
The proposed CMCPS method was successfully applied to
determine CLO in biological ﬂuids and the results obtained
are summarized in Table 5. The determination of CLO in
spiked human serum shows that a wide concentration range
of the drug can be determined by the investigated sensor with
high precision and accuracy. In urine samples the standard
addition technique was applied to overcome the matrix effects
in these samples. Also, the response times of the proposed sen-
sors are instant (within 15 s), so the sensors are rapidly trans-
ferred back and forth between the biological samples and the
bi-distilled water between measurements to protect the sensing
component from adhering to the surface of some matrix com-
ponents. It is concluded that the proposed sensors can be suc-
cessfully applied to in vitro studies and for clinical use. This
conﬁrms that the sensitivity and limit of quantiﬁcation
(LOQ) are adequate for determination of clopidogrel bisulfate
in pharmacokinetic studies.
3.9.3. Potentiometric monitoring of Plavix tablet dissolution
Liddell et al., 2007; United States Pharmacopeia, 2009
The dissolution test was operated at 50 rpm in 900 ml 1.0x102
M hydrochloric acid (simulated duodenum ﬂuid), and potenti-
ometric clopidogrel sensor was used. The simulated duodenumfate in plavix tablet and human biological ﬂuids utilizing chemically modiﬁed
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Table 4 Selectivity coefﬁcient values for log Kpot
Drug;Jzþ CLO-ST/CMCPS.
Interferentb MPMa SSM Interferentb MPMa SSM
K+ 2.88 3.15 Cr3+ 3.33 4.20
Na+ 2.95 3.33 Maltose 3.52 —
NH4
+ 2.65 2.93 Glucose 3.50 —
Ba2+ 3.21 3.55 Lactose 3.54 —
Cu2+ 3.20 3.62 Urea 3.23 —
Co2+ 3.11 3.55 Ascorbic acid 3.30 —
Ni2+ 3.19 3.65 Aspirin 1.15 —
Mn2+ 2.56 3.11 L-Lysine 3.34 —
Mg2+ 2.89 3.36 L-Cystine 3.20 —
Zn2+ 2.67 3.28 L-Glycine 3.19 —
Fe3+ 3.27 3.76 L-Theronine 3.44 —
a Each value is the average of three determinations. (—): No response.
b All interferent ions are in the form of chloride solution (0.5 M for MPM) and (103 M for SSM).
Table 5 Determination of clopidogrel bisulfate in bulk solutions, tablet, urine and serum applying the standard addition method,
calibration curve method and potentiometric titrations.
Taken (mg) Recovery (%) R.S.D.% Taken (mg) Recovery (%) R.S.D.%
I-Standard addition methoda
Bulk powder Plavix tablets
2.1 99.1 0.63 2.1 99.0 0.22
4.2 99.3 0.55 4.2 98.9 0.48
6.3 99.0 0.81 6.3 98.0 0.51
8.4 98.2 0.64
II-Calibration curve method
Bulk powder Plavix tablets
6.3 99.3 2.1 98.4
8.4 98.6 4.2 98.5
12.6 98.0 6.3 98.7
Spiked human seruma Spiked urinea
2.1 98.3 0.67 2.1 99.0 0.21
4.2 98.0 0.48 4.2 98.6 0.24
6.3 97.6 1.09 6.3 98.3 0.43
III-Potentiometric titrations
Bulk powder Plavix tablets
STA as titrant
6.3 99.6 0.50 98.5 0.65
8.4 99.1 0.77 98.1 1.41
12.6 99.0 0.89 98.0 1.08
21.0 98.2 0.99 97.3 0.97
PTA as titrant
4.2 99.3 0.77 99.0 1.05
12.6 98.7 0.59 98.6 1.04
21.0 98.0 0.47 98.5 1.18
29.4 98.0 0.68 98.2 0.96
42.0 97.6 0.78 97.0 1.44
SMA as titrant
2.1 99.7 0.44 99.0 0.85
4.2 99.3 0.67 99.4 0.64
6.3 99.0 0.78 98.6 0.84
8.4 98.5 0.51 98.0 0.77
12.6 98.3 0.73 98.2 1.11
29.4 98.0 0.80 97.0 1.23
PMA as titrant
4.2 99.8 0.16 99.5 0.84
6.3 99.4 0.77 99.3 0.26
8.4 99.0 0.78 99.1 0.65
12.6 98.5 0.58 98.5 0.91
29.4 98.0 0.88 98.0 0.38
42.0 98.3 0.30 97.8 0.69
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Figure 6 Potentiometric titrations of 21.0 mg CLO-H2SO4 with
PMA (a), PTA (b), SMA (c), and STA (d) As titrants using CLO-
ST/CMCPS.
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Figure 7 Dissolution proﬁles of 75 mg clopidogrel bisulfate
tablet obtained by potentiometric: 5.0% CLO-CMCPS, and
spectrophotometric measurements at 240 nm.
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products in the vitro test. The compression recipients do not
interfere. Taking into account the S-shape of the dissolution
curve obtained Fig. 6. It shows that clopidogrel releases
immediately after capsule was ruptured. More than 75% drug
was released within 15 min and complete dissolution was
achieved in 120 min.
In the potentiometric method, the potential values were con-
tinuously recorded at 1-min time intervals and compared with a
calibration graph. For the UV spectrophotometric assay, ﬁxed
volumes of the dissolution medium were withdrawn, diluted
with 0.01 M HCl, measured at k max 240 nm and compared
with a calibration graph. Fig. 7 shows the dissolution proﬁlesTable 6 Statistical treatment of data obtained for the determinatio
Method X± S.E. Relative error (%) F3.3 value
Bulk powder
Oﬃcial method(35) 98.0 ± 0.50 0.851
Method (I) 99.2 ± 0.11 0.891 0.785
Method (II) 99.5 ± 0.46 0.624 0.748
Method (III) 99.7 ± 0.06 0.339 0.806
Spiked urine
Oﬃcial method(35) 98.0 ± 0.44 0.822
Method (I) 98.7 ± 0.73 0.621 0.625
Method (I): The standard addition method.
Method (II): The Calibration curve method.
Method (III): The Potentiometric titrations method.
X ± S.E.: Recovery ± standard error.
F-tabulated is 6.39 at 95.0% conﬁdence limit.
t-tabulated at 99.0% conﬁdence limit and 6 degrees of freedom.
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results obtained by spectrophotometry and potentiometry are
almost identical. The use of the potentiometric method sensor,
however, has the advantage of in situ monitoring.
3.9.4. Robustness and ruggedness
The robustness method of the CLO-CMCPS was examined by
changed the aqueous solution to acetate buffer pH 4 ± 0.5 and
the percentage result was 99.79 ± 0.23 mV/decade for the
CLO-ST.
This result was closely in agreement with those obtained
from standard drug solution, (Table 1). While the ruggedness
or the reproducibility was checked by using another model
of pH-meter (Jenway, 3505) was indicated by the results
obtained as percentage was 99.83 ± 0.26 mV/decade for the
same sensor. (Table 1).
3.9.5. Content uniformity assay of Plavix tablets
The proposed ISE method described good accuracy and preci-
sion for the quality control tests, the content uniformity assay
showed that accurate and reproducible results so the sensor
can be employed for quantiﬁcation of clopidogrel and the
recovery of CLO-H2SO4 is almost quantitative.n of CLO using the CLO-ST/CMCPS.
(9.28) X ± S.E. Relative error (%) F3.3 value (9.28)
Tablet
97.0 ± 0.6 0.90
98.6 ± 0.112 0.621 0.566
98.9 ± 0.013 0.651 0.901
99.5 ± 0.372 0.917 0.739
Spiked human serum
98.1 ± 0.2 0.911
98.5 ± 0.035 0.481 0.577
fate in plavix tablet and human biological ﬂuids utilizing chemically modiﬁed
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Table 7 Comparison between some of the published and the suggested methods for determination of CLO-ion.
ISS Reference Saber et al. (2008) Ref Bin-Ibrahim et al. (2012) [C.S.]
TpClPB-(PVC) (PMA) (ARS) (PTA) CMCPS
(DBP) (2-NPPE)
Parameter o-NPOE DOP Plastic Coated-Ag Coated-graphite CLO-ST
Slope (mV/decade) 61.7 59.3 55.97 57.57 58.03 ± 0.150 60.0 ± 0.5
Correlation coeﬃcient (r) 0.9874 0.9993 0.9998 0.9999 0.9999 0.9999
Linear range (M) – – 1 · 107–1 · 102 1 · 107–1 · 102
LOD (M) 1.0 · 105 5.01 · 108 4.1 · 108 5.0 · 108 3.5 · 108
Working pH range 1.5 – 4.0 1.2–4.6 1.2 – 4.8
Response time (s) 20 25 15 68
Life span/days 77 84 25 30 40 Fresh surface
Accuracy (%) – – 99.09 ± 0.6 99.72 ± 0.24 99.28 ± 0.857 99.87 ± 0.177
Standard deviation – – 0.460 0.227 0.150 0.326
Robustness 99.48 ± 0.537 99.36 ± 0.337 99.51 ± 0.445 99.79 ± 0.23
Ruggedness 99.51 ± 0.430 99.26 ± 0.650 98.77 ± 0.199 99.83 ± 0.26
r2: Correlation coefﬁcient; R%: Mean recovery %; C.S.: Current Study.
10 A.F. Khorshid3.9.6. Statistical treatment of results
The results obtained from the potentiometric determination of
the drug in these real samples are given in Table 5. The results
of the recoveries of CLO applying the standard addition
method, calibration curve method and the potentiometric
titration were evaluated statistically and compared with the
values obtained with the pharmacopeia method by applying
the F-tests (Miller and Miller, 1994) The values obtained
(Table 6) show that the present methods have a precision
comparable to that of the pharmacopeia method. However,
the proposed methods are more practical regarding time of
analysis, consumption of solvents and sample pretreatment
requirements for spectrophotometric or chromatographic
analysis of clopidogrel bisulfate.
3.9.7. Comparison of the clopidogrel selective sensors
The performance characteristics of the proposed sensor and
those of some reported ISE method are presented in Table 7
for comparison. It is clear that the proposed sensor CMCPS
is comparable with most of the reported sensors with regard
to working concentration range, response time and low
detection limit. Overall evaluation indicates this sensor is more
useful in such applications.
4. Conclusion
The proposed potentiometric methods based on the construc-
tion of different types of selective sensors with ion exchangers
might be useful analytical characteristics for the determination
of CLO in its bulk solutions, pharmaceutical dosage form and
biological human ﬂuids. The good recoveries and low relative
standard deviations obtained reﬂect the high accuracy and pre-
cision of the proposed method. Moreover, the CMCPS is sim-
ple in construction and fabrication, easy to operate in
mechanism, high sensitivity sensor, and reasonable selectivity
for variables ions, fast static response dynamic time, long term
stability for drug solution and applicability over a wide
concentration range with minimal sample pretreatment and
inexpensive making it an excellent tool for the routine determi-
nation of CLO in quality control laboratories. The sensorPlease cite this article in press as: Khorshid, A.F. New analysis of clopidogrel bisul
carbon paste sensor. Arabian Journal of Chemistry (2014), http://dx.doi.org/10.101developed is superior as compared with the clopidogrel
selective sensor described in the literature (Saber et al., 2008;
Bin-Ibrahim et al., 2012).Acknowledgements
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